Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
25.75
-2.15 (-7.71%)
At close: Oct 2, 2026, 4:00 PM EDT
26.22
+0.47 (1.83%)
After-hours: Oct 2, 2026, 7:32 PM EDT
Nanobiotix Employees
Nanobiotix had 100 employees as of December 31, 2025. The number of employees decreased by 8 or -7.41% compared to the previous year.
Employees
100
Change (1Y)
-8
Growth (1Y)
-7.41%
Revenue / Employee
$131,452
Profits / Employee
-$603,976
Market Cap
1.31B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 100 | -8 | -7.41% | 100 | 0 |
| Dec 31, 2024 | 108 | 6 | 5.88% | 108 | 0 |
| Dec 31, 2023 | 102 | 0 | - | 102 | 0 |
| Dec 31, 2022 | 102 | 2 | 2.00% | 102 | 0 |
| Dec 31, 2021 | 100 | 10 | 11.11% | 100 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| Replimune Group | 465 |
| Kardigan | 241 |
| Omeros | 175 |
| Alpha Tau Medical | 121 |
| ORIC Pharmaceuticals | 111 |
| ArriVent BioPharma | 77 |
| Avalyn Pharma | 55 |
NBTX News
- 2 days ago - Nanobiotix Names Arnd Christ CFO As Rhijn Steps Down - Nasdaq
- 3 days ago - Nanobiotix (NBTX) Names Arnd Christ as CFO Amid Share Price Drop - GuruFocus
- 3 days ago - Nanobiotix appoints Arnd Christ CFO - TheFly
- 3 days ago - NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer - GlobeNewsWire
- 5 days ago - Nanobiotix S.A. (NBTX) Earnings Review: Clinical Progress Meets a Cash-Runway Test - AlphaStreet
- 10 days ago - Nanobiotix (NBTX) Faces High Price-to-Sales Valuation Amid Continued Losses - GuruFocus
- 10 days ago - NANOBIOTIX Provides First Half 2026 Operational and Financial Update - GlobeNewsWire
- 10 days ago - Nanobiotix Earnings release: H1 2026 - Filings